Elongator and the role of its subcomplexes in human diseases

The Elongator complex was initially identified in yeast, and a variety of distinct cellular functions have been assigned to the complex. In the last decade, several research groups focussed on dissecting its structure, tRNA modification activity and role in translation regulation. Recently, Elongator emerged as a crucial factor for various human diseases, and its involvement has triggered a strong interest in the complex from numerous clinical groups. The Elongator complex is highly conserved among eukaryotes, with all six subunits (Elp1‐6) contributing to its stability and function. Yet, recent studies have shown that the two subcomplexes, namely the catalytic Elp123 and accessory Elp456, may have distinct roles in the development of different neuronal subtypes. This Commentary aims to provide a brief overview and new perspectives for more systematic efforts to explore the functions of the Elongator in health and disease.

[1]  V. J. Planelles-Herrero,et al.  Elongator stabilizes microtubules to control central spindle asymmetry and polarized trafficking of cell fate determinants , 2022, Nature Cell Biology.

[2]  L. Nguyen,et al.  Elp3‐mediated codon‐dependent translation promotes mTORC2 activation and regulates macrophage polarization , 2022, The EMBO journal.

[3]  Melissa J. Davis,et al.  Functional divergence of the two Elongator subcomplexes during neurodevelopment , 2022, EMBO molecular medicine.

[4]  Melissa J. Davis,et al.  Elp2 mutations perturb the epitranscriptome and lead to a complex neurodevelopmental phenotype , 2021, Nature Communications.

[5]  S. Glatt,et al.  How Elongator Acetylates tRNA Bases , 2020, International journal of molecular sciences.

[6]  Jennifer L. Hadley,et al.  Germline Elongator mutations in Sonic Hedgehog medulloblastoma , 2020, Nature.

[7]  Hui Shen,et al.  Genome-wide CRISPR screen identifies ELP5 as a determinant of gemcitabine sensitivity in gallbladder cancer , 2019, Nature Communications.

[8]  T. Brochier,et al.  Reciprocal regulation of TORC signaling and tRNA modifications by Elongator enforces nutrient-dependent cell fate , 2019, Science Advances.

[9]  M. Talkowski,et al.  ELP1 Splicing Correction Reverses Proprioceptive Sensory Loss in Familial Dysautonomia. , 2019, American journal of human genetics.

[10]  S. Glatt,et al.  Roles of Elongator Dependent tRNA Modification Pathways in Neurodegeneration and Cancer , 2018, Genes.

[11]  P. Sah,et al.  Elongator mutation in mice induces neurodegeneration and ataxia-like behavior , 2018, Nature Communications.

[12]  Sebastian A. Leidel,et al.  Codon-specific translation reprogramming promotes resistance to targeted therapy , 2018, Nature.

[13]  M. Hagiwara,et al.  RBM24 promotes U1 snRNP recognition of the mutated 5′ splice site in the IKBKAP gene of familial dysautonomia , 2017, RNA.

[14]  E. C. Ibrahim,et al.  Proteasome inhibitors to alleviate aberrant IKBKAP mRNA splicing and low IKAP/hELP1 synthesis in familial dysautonomia , 2017, Neurobiology of Disease.

[15]  Sebastian A. Leidel,et al.  Elp3 links tRNA modification to IRES-dependent translation of LEF1 to sustain metastasis in breast cancer , 2016, The Journal of experimental medicine.

[16]  Tharun,et al.  Elp 3 links tRNA modification to IRES-dependent translation of LEF 1 to sustain metastasis in breast cancer , 2016 .